Physician

Richard Alexan-Shirabad, M.D.

According to 2025 Medicare claims, Richard Alexan-Shirabad, M.D. (NPI: 1104859909) practices neurology in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is RICHARD ALEXAN MD INC (NPI: 1770748014; TIN: 262899331) and primary practice location at 93309-0419. Alexan-Shirabad is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Alexan-Shirabad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,241 traditional Medicare patients, billed 99,789 HCPCS/CPT codes, and received $939,252 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,897 prescription claims across 521 beneficiaries totaling $2,027,479 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 22 claims. Open Payments data shows 315 records totaling $9,042. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $359,510 to $939,252. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,154,260 to $2,027,479. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,117 and ending at $8,205.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$514K$1.0M2015 Medicare payment: $359,510 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $385,396 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $430,671 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $436,074 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $720,315 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $630,847 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $770,472 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $941,070 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,028,584 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $939,252 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201589110,444$359,510
201692512,891$385,396
201789413,101$430,671
20181,10213,987$436,074
20191,42322,962$720,315
20201,25130,395$630,847
20211,18035,271$770,472
20221,29047,114$941,070
20231,24549,427$1,028,584
20241,24199,789$939,252

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $1,154,260 (USD; Tot_Drug_Cst)2016 Drug cost: $1,125,363 (USD; Tot_Drug_Cst)2017 Drug cost: $1,102,248 (USD; Tot_Drug_Cst)2018 Drug cost: $1,637,602 (USD; Tot_Drug_Cst)2019 Drug cost: $2,536,280 (USD; Tot_Drug_Cst)2020 Drug cost: $2,918,048 (USD; Tot_Drug_Cst)2021 Drug cost: $2,713,083 (USD; Tot_Drug_Cst)2022 Drug cost: $2,574,175 (USD; Tot_Drug_Cst)2023 Drug cost: $2,366,866 (USD; Tot_Drug_Cst)2024 Drug cost: $2,027,479 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154783,642$1,154,260
20164433,162$1,125,363
20174082,866$1,102,248
20185292,960$1,637,602
20197074,557$2,536,280
20206213,974$2,918,048
20215933,324$2,713,083
20225503,589$2,574,175
20235373,365$2,366,866
20245212,897$2,027,479

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.5K$3.1K2015 Medicare payment: $3,058 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $407 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $250 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R16$3,058
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R11$407
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R22$250

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more222222$158
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more184215$116
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more194194$106
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more649988$80
95886Needle measurement of electrical activity in arm or leg muscles, complete study191434$73

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5027686$366,069
NuplazidPimavanserin Tartrate371,650$268,252
Kesimpta PenOfatumumab16464$167,464
BetaseronInterferon Beta-1b13364$124,754
IngrezzaValbenazine Tosylate16480$123,826

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
K0003Lightweight wheelchairYN/R11$182
K0195Elevating leg rests, pair (for use with capped rental wheelchair base)YN/R11$68

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.315$9,042TG Therapeutics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard Alexan-Shirabad, M.D.?

Tedicare shows public-source Medicare data for Richard Alexan-Shirabad, M.D. (NPI 1104859909), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Alexan-Shirabad, M.D. have ACO affiliation data?

Richard Alexan-Shirabad, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Richard Alexan-Shirabad, M.D.?

Richard Alexan-Shirabad, M.D. is linked to RICHARD ALEXAN MD INC (billing NPI 1770748014) in the available physician profile data.

Does Richard Alexan-Shirabad, M.D. have Open Payments data?

Richard Alexan-Shirabad, M.D. has 315 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.